Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Heelan

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Radiologic Clinics of North America|December 13, 2006
Lung cancerMichelle S Ginsberg, Ravinder K Grewal, Robert T Heelan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesotheliomaLee M Krug, Robert T Heelan, Mark G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Molecular on/off switchDaniel T Milton, Gregory J Riely, William Pao, et al.
Cancer|February 25, 2003
Overdiagnosis in chest radiographic screening for lung carcinoma: frequencyDavid F Yankelevitz, William J Kostis, Claudia I Henschke, et al.
Journal of Clinical Pathology|March 7, 2015
A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumoniaMarc B Feinstein, Shilpa A DeSouza, Andre L Moreira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Influence of type of cigarette on peripheral versus central lung cancerDaniel R Brooks, John H M Austin, Robert T Heelan, et al.
Plos Medicine|February 8, 2005
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinibWilliam Pao, Theresa Y Wang, Gregory J Riely, et al.
Cancer|April 7, 2005
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trialLee M Krug, John P Crapanzano, Christopher G Azzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 2004
Practical management of patients with non-small-cell lung cancer treated with gefitinibNeelam T Shah, Mark G Kris, William Pao, et al.
Cancer|August 1, 2006
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerDaniel T Milton, Christopher G Azzoli, Robert T Heelan, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Radiologic Clinics of North America|December 13, 2006
Lung cancerMichelle S Ginsberg, Ravinder K Grewal, Robert T Heelan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesotheliomaLee M Krug, Robert T Heelan, Mark G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Molecular on/off switchDaniel T Milton, Gregory J Riely, William Pao, et al.
Cancer|February 25, 2003
Overdiagnosis in chest radiographic screening for lung carcinoma: frequencyDavid F Yankelevitz, William J Kostis, Claudia I Henschke, et al.
Journal of Clinical Pathology|March 7, 2015
A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumoniaMarc B Feinstein, Shilpa A DeSouza, Andre L Moreira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Influence of type of cigarette on peripheral versus central lung cancerDaniel R Brooks, John H M Austin, Robert T Heelan, et al.
Plos Medicine|February 8, 2005
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinibWilliam Pao, Theresa Y Wang, Gregory J Riely, et al.
Cancer|April 7, 2005
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trialLee M Krug, John P Crapanzano, Christopher G Azzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 2004
Practical management of patients with non-small-cell lung cancer treated with gefitinibNeelam T Shah, Mark G Kris, William Pao, et al.
Cancer|August 1, 2006
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerDaniel T Milton, Christopher G Azzoli, Robert T Heelan, et al.
Pageof 2